Recent studies show that while drugs like Ozempic and Wegovy have revolutionized weight management, they also come with significant limitations that users should understand. The drugs, which contain GLP-1 receptor agonists, offer substantial benefits but present challenges including side effects, cost barriers, and the fact that weight typically returns when patients stop treatment. What These Drugs Actually Do Both Ozempic and Wegovy contain semaglutide, a compound that mimics the GLP-1 hormone in our bodies. This hormone regulates blood sugar and controls appetite signals in the brain. “When we talk about obesity as a disease, it’s not just about excess fat … Continue reading Weight Loss with Ozempic and Wegovy Often Reversed Post-Treatment